Impact of Premedication De-Escalation on Incidence of Infusion-Related Reactions With Daratumumab.
Saved in:
| Title: | Impact of Premedication De-Escalation on Incidence of Infusion-Related Reactions With Daratumumab. |
|---|---|
| Authors: | Vazirnia D; Mayo Clinic Arizona, Phoenix, AZ., Del Rio Verduzco A; Mayo Clinic Healthcare System-Eau Claire, Eau Claire, WI., Soefje SA; Mayo Clinic Rochester, Rochester, MN., Sanders KA; Mayo Clinic Arizona, Phoenix, AZ., Sandahl TB; Mayo Clinic Rochester, Rochester, MN. |
| Source: | JCO oncology practice [JCO Oncol Pract] 2026 Jun; Vol. 22 (6), pp. 1049-1055. Date of Electronic Publication: 2024 Feb 26. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101758685 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2688-1535 (Electronic) Linking ISSN: 26881527 NLM ISO Abbreviation: JCO Oncol Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 2688-1535 |
|---|---|
| DOI: | 10.1200/OP.23.00470 |
